Xeris Biopharma Holdings, Inc. (XERS)

Typically moves ±9.03% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

Since Nov 10, 2021, Xeris Biopharma Holdings, Inc. (XERS) has reported earnings 19 times. On average the shares move ±9.03% post-earnings, with a positive reaction 57.9% of the time. Its largest post-earnings gain was +20.22% (Aug 07, 2025) and its largest decline was -21.88% (Nov 06, 2025). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings reactions

How XERS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.03%

Positive %

57.9%

Negative %

42.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☀ PRE	+4%	open_in_new
Mar 02, 2026	☀ PRE	-1.63%	open_in_new
Nov 06, 2025	☀ PRE	-21.88%	open_in_new
Aug 07, 2025	☀ PRE	+20.22%	open_in_new
May 08, 2025	☀ PRE	+15.18%	open_in_new
Mar 06, 2025	☀ PRE	+9.55%	open_in_new
Nov 08, 2024	☀ PRE	+3.27%	open_in_new
Aug 08, 2024	☀ PRE	+4.69%	open_in_new
May 09, 2024	☀ PRE	+1.62%	open_in_new
Mar 06, 2024	☀ PRE	-19.48%	open_in_new
Nov 09, 2023	☀ PRE	-8.59%	open_in_new
Aug 08, 2023	☀ PRE	+3.61%	open_in_new
May 09, 2023	☀ PRE	+13.75%	open_in_new
Mar 08, 2023	☀ PRE	-11.76%	open_in_new
Nov 09, 2022	☀ PRE	-1.33%	open_in_new
Aug 10, 2022	☀ PRE	+13.53%	open_in_new
May 11, 2022	☀ PRE	-8.38%	open_in_new
Mar 10, 2022	☀ PRE	+6.07%	open_in_new
Nov 10, 2021	☀ PRE	-3.06%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.03%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 19 →

Funds holding

$152770844

Total value held

Buying

13 added · 6 reduced

Blackrock, Inc.

$75085553 +2.42%

State Street Corp

$27017409 +13.15%

Morgan Stanley

$14921395 -4.99%

Goldman Sachs Group Inc

$9359170 +2.88%

Northern Trust Corp

$8378778 +4.17%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260717	open_in_new SEC.gov
144	20260707	open_in_new SEC.gov
4	20260707	open_in_new SEC.gov
144	20260706	open_in_new SEC.gov
3	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
144	20260701	open_in_new SEC.gov
144	20260701	open_in_new SEC.gov

Frequently asked about XERS earnings

When does Xeris Biopharma Holdings, Inc. report earnings next? expand_more

Xeris Biopharma Holdings, Inc. (XERS)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does XERS stock move after earnings? expand_more

Over 19 reports, XERS has moved an average of ±9.03% the session after earnings, closing higher 57.9% of the time.

What was XERS's biggest post-earnings move? expand_more

XERS's largest post-earnings gain on record was +20.22% on Aug 07, 2025, and its largest decline was -21.88% on Nov 06, 2025.

Where can I find Xeris Biopharma Holdings, Inc.'s SEC filings? expand_more

All of Xeris Biopharma Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.